Skip to main content

Table 3 Laboratory findings of the studied patients

From: Role of shear wave elastography in characterization of hepatic focal lesions

Lab investigationsBenign lesions, N = 28 (25.45%)Malignant lesions, N = 82 (74.54%)χ2p value
CBCRBCS (mean ± SD)4.7 ± 0.234.5 ± 0.520.7510.420
WBCS (mean ± SD)5876.2 ± 911.25395.1 ± 1037.11.560.120
Platelets (mean ± SD)250.3 ± 39.4198.2 ± 67.232.7450.009
VirologyNegative10 (71.4%)2 (4.9%)27.650.001
Hepatitis B1 (7.1%)11 (26.8%)
Hepatitis C3 (21.4%)28 (68.3%)
Liver functionsBilirubin (mean ± SD)1.23 ± 1.672.06 ± 3.60.7510.411
Albumin (mean ± SD)3.9 ± 0.23.52 ± 0.542.6410.013
SGOT (mean ± SD)38.32 ± 12.3557.32 ± 23.102.8320.006
SGPT (mean ± SD)39.1 ± 14.2056.32 ± 16.143.2140.002
Renal functionsCreatinine (mean ± SD)3.9 ± 1.201.2 ± 0.211.6520.095
Urea (mean ± SD)32.1 ± 6.2537.2 ± 5.642.7410.008
INR(mean ± SD)0.91 ± 0.070.97 ± 0.170.8510.376
PC(mean ± SD)75.2 ± 5.1272.4 ± 8.320.9410.351
Tumor markersAFP (mean ± SD)22.1 ± 14.32504.32 ± 387.14.6510.001